Immunosuppression in patients who die of sepsis and multiple organ failure. - Test2 - elhamkhani - TriplyDB

Immunosuppression in patients who die of sepsis and multiple organ failure.

Immunosuppression in patients who die of sepsis and multiple organ failure.

http://www.wikidata.org/entity/Q35991015

about

Immunotherapy for the Adjunctive Treatment of Sepsis: From Immunosuppression to Immunostimulation. Time for a Paradigm Change?Ulinastatin and thymosin as immune modulators for the treatment of sepsis Ulinastatin and thymosin as immune modulators for the treatment of sepsis Immune responsive gene 1 (IRG1) promotes endotoxin tolerance by increasing A20 expression in macrophages through reactive oxygen species The role of neutrophils in immune dysfunction during severe inflammation Detrimental cross-talk between sepsis and acute kidney injury: new pathogenic mechanisms, early biomarkers and targeted therapies Sirtuins Link Inflammation and Metabolism The First Line of Defense: The Effects of Alcohol on Post-Burn Intestinal Barrier, Immune Cells, and Microbiome How Neutrophils Shape Adaptive Immune Responses CD1d- and MR1-Restricted T Cells in Sepsis Septic Shock: Advances in Diagnosis and Treatment Biomarkers of sepsis Immunomodulation in sepsis: the role of endotoxin removal by polymyxin B-immobilized cartridge Current challenges in understanding immune cell functions during septic syndromes The inflammatory response in sepsis Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies Effect of parenteral selenium supplementation in critically ill patients: a systematic review and meta-analysis Immunosuppression after sepsis: systemic inflammation and sepsis induce a loss of naïve T-cells but no enduring cell-autonomous defects in T-cell function Microparticles: markers and mediators of sepsis-induced microvascular dysfunction, immunosuppression, and AKI The role of genetics and antibodies in sepsis Understanding Long-Term Outcomes Following Sepsis: Implications and Challenges Septic encephalopathy: when cytokines interact with acetylcholine in the brain Soluble tumor necrosis factor related apoptosis inducing ligand level as a predictor of severity of sepsis and the risk of mortality in septic patients Park7 interacts with p47(phox) to direct NADPH oxidase-dependent ROS production and protect against sepsis Programmed Cell Death-1/Programmed Death-ligand 1 Pathway: A New Target for Sepsis Inhibition of histone deacetylase 6 restores innate immune cells in the bone marrow in a lethal septic model Emerging therapeutic targets of sepsis-associated acute kidney injury.Guidelines for the assessment and acceptance of potential brain-dead organ donors.Toll-like receptor 4 stimulation before or after Streptococcus pneumoniae induced sepsis improves survival and is dependent on T-cells.Innate immune function and mortality in critically ill children with influenza: a multicenter study Why do they die? Comparison of selected aspects of organ injury and dysfunction in mice surviving and dying in acute abdominal sepsis CRISPLD2 is expressed at low levels during septic shock and is associated with procalcitonin Increased CD4(+) T cell co-inhibitory immune receptor CEACAM1 in neonatal sepsis and soluble-CEACAM1 in meningococcal sepsis: a role in sepsis-associated immune suppression?Downregulation of Blood Monocyte HLA-DR in ICU Patients Is Also Present in Bone Marrow Cells.Pathophysiology of Pediatric Multiple Organ Dysfunction Syndrome.The SPEED (sepsis patient evaluation in the emergency department) score: a risk stratification and outcome prediction tool.Protectin DX increases survival in a mouse model of sepsis by ameliorating inflammation and modulating macrophage phenotype.Concise Review: Mesenchymal Stromal Cell-Based Approaches for the Treatment of Acute Respiratory Distress and Sepsis Syndromes.T-cell Co-inhibitory Molecules in Sepsis-induced Immunosuppression: From Bench to Bedside.Reactivation of multiple viruses in patients with sepsis.

P2860

Q22306306-7E3FE74E-D2EC-4FD7-8F72-BD4EFBF15819 Q24193380-36688135-C7E3-43CE-9CAC-26410DD009EE Q24202365-FFE8CA49-4B88-4D29-B222-9221760E61EA Q24338871-9CBBAF96-9AEE-4699-8157-ACDA35658D19 Q26752629-BA3C5A90-397D-4E5A-9E4D-74C51D26C6CB Q26765788-1525A6B1-76D0-46CA-A87C-414B1676859E Q26767141-C3A52EBC-81AF-4A01-954E-EC89E0DEC596 Q26773231-F732A70A-F1A6-4350-85D6-91E7732EF305 Q26781286-12489E4D-1B40-4797-BAC0-8AB3F77C1FC4 Q26796132-45AD1774-8CE3-49DE-ABB7-6D6668763D60 Q26797235-E605D935-3467-469B-8B78-904D6CC3E211 Q26822575-7FCB6447-FD07-413E-9DD0-44821BEFA766 Q26830445-F0843E5B-63E6-454F-B219-2356E599FDE2 Q26849252-DE3D80FC-7327-4C4F-8C9F-A6864EDEADD9 Q26849300-EBEADA10-4F4F-4216-A17D-BE24CFB5D349 Q26852697-FC4E27EB-1CB4-4857-A3E7-A05D2E907827 Q27022375-F50A3336-A3E9-4E1E-888F-2598137C880C Q27320494-ECDF3284-4E77-4528-BF87-8ADAF4BEB8D7 Q27694575-FCAC1B4C-01FC-493F-BCA1-4A1B5284F4F3 Q28075279-035AD3EE-A62B-4867-831D-FF2D06995264 Q28078162-A0FE5D7B-746D-4C5A-8A31-8FA29CE3FC5D Q28082616-8D5AA303-B6E2-44A5-9B4A-7BE4710DD703 Q28537588-B2F317D7-68C0-4191-9D3C-FD66F48DF11E Q28592872-8B8EBDA0-C507-4472-A35F-74E519B05341 Q29994668-4CC147E7-F2DA-451D-842E-5C3AA8EF6C86 Q30144009-C80C8B74-2520-4F45-A947-8EFA1D9A025D Q30300333-26A75AA1-DB28-4778-9C1D-1DFBDC4B04C4 Q30372798-AE4D5ABF-7D18-46C9-93F5-89509A797CE7 Q30415195-6BFFC7A0-25CF-4F72-B3F7-B147121F9320 Q30418318-B78436B2-C3ED-450D-82F7-EEED29ED55DA Q30658795-03FEAB69-FC36-4FC7-818D-D3913CD5A826 Q31120386-1861D1E1-9888-4B3C-B46D-9B4DCC69FEC9 Q31124179-5CB395AC-708F-4823-9C2D-DE7E555F2B69 Q33437159-432E36B4-42E4-4481-B964-857FD593D383 Q33439759-715C53D3-62FE-4A75-BF5D-75C987F80B40 Q33637794-1B367F68-832A-4972-A736-E74196CA2B0F Q33668911-3A8B1E62-E990-4DA7-9C15-130F5468D1B9 Q33722631-0B3FEEFF-5823-4152-BCEF-959EA027F459 Q33723244-0A437001-DD8D-4EC0-A69E-CAAEE369A476 Q33740315-7C558F03-542A-4D3A-8B3C-E5AD24DF32E4

P2860

Immunosuppression in patients who die of sepsis and multiple organ failure.

http://www.wikidata.org/entity/Q35991015

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Immunosuppression in patients who die of sepsis and multiple organ failure.

@ast

Immunosuppression in patients who die of sepsis and multiple organ failure.

@en

type

label

Immunosuppression in patients who die of sepsis and multiple organ failure.

@ast

Immunosuppression in patients who die of sepsis and multiple organ failure.

@en

prefLabel

Immunosuppression in patients who die of sepsis and multiple organ failure.

@ast

Immunosuppression in patients who die of sepsis and multiple organ failure.

@en

P1433

Q35991015-0E8B2814-4A7B-423C-8E49-15B5663DA5B1

P1476

Q35991015-2AD6754D-5496-47EB-8388-7B783C45286B

P2093

Q35991015-1D0B1009-BB24-4DD9-833A-496906025EBD

Q35991015-2EB7A31D-EA11-4012-AD85-C3EB61B39E17

Q35991015-38800CE6-A91B-4C1D-8D10-DB69AE2B270A

Q35991015-4B82583F-4DBA-4779-94E4-2FF633A5CAEE

Q35991015-4C567EE8-182A-4BDF-829D-43DA0149C16C

Q35991015-6B14D7DB-F773-46AF-95F7-2B1E86D74877

Q35991015-6C50B7FF-1BAB-4BEA-A8CD-408F401A0325

Q35991015-810C964A-1171-49A3-BD15-63EDCE7DFF9C

Q35991015-AF25D001-7A88-4A11-89F1-453D1BEDBD36

Q35991015-B990F2DE-59D3-4E33-8067-C74949D4A3CA

P2860

Q35991015-07691159-75D2-40B2-83E9-DB2EA70C3820

Q35991015-0B878C3E-E774-486C-8BC0-C78FBA1C12A3

Q35991015-1073D44D-182C-4E65-8CB8-1D14F7D1965B

Q35991015-135AE5FD-08C5-4A12-AB2A-7EF0AD845389

Q35991015-1BEED44C-95EF-4D6C-817E-D79815E74EE8

Q35991015-20AE9388-C49A-4730-AABD-F9652CAC9EA8

Q35991015-246A49AB-6944-4ED5-85F0-A3EB1248471A

Q35991015-271F03E6-1193-49AC-BE9C-0DF96655E151

Q35991015-2D1B119B-DE1E-4F82-9C9E-209205FCBEBF

Q35991015-2F5F6476-90D0-4E03-8A6D-5B9275A3AE8A

P304

Q35991015-8A824459-B1AF-4C1D-A285-4338EC84C056

P31

Q35991015-72EFAACF-9639-4323-87C6-403C6716C1DA

P356

Q35991015-2C703A37-EB7C-447A-86BF-84232BE0EB6F

P407

Q35991015-02C33A81-F4AB-43DC-B94B-3EAFD748BA79

P433

Q35991015-6BA87D9A-CACF-43F3-9671-F429A0654F99

P478

Q35991015-2A1A230F-47FE-4F4E-B0CA-9DE088189767

P50

Q35991015-04B5CDC3-18A2-4D78-8707-896D0E39CAC7

P577

Q35991015-F0A703CD-6657-4E35-9C24-229434A6272D

P5875

Q35991015-C0E0EBAC-BB55-45B0-A39C-6173897C2921

P698

Q35991015-F98C37FA-331E-44BD-88E6-5ACB259D9FBC

P921

Q35991015-516A8C9E-0F30-49EA-9A4F-148CD51FA103

Q35991015-7EE201BB-99BC-4067-8904-D20442ABD670

P932

Q35991015-CADC175E-DB6E-4E0C-9595-452400317B74

P356

P1433

Journal of the American Medical Association

P1476

Immunosuppression in patients who die of sepsis and multiple organ failure.

@en

P2093

Alexander S Krupnick

http://www.w3.org/2001/XMLSchema#string

Andrew H Walton

http://www.w3.org/2001/XMLSchema#string

Anil Srivastava

http://www.w3.org/2001/XMLSchema#string

Dale F Osborne

http://www.w3.org/2001/XMLSchema#string

Daniel Kreisel

http://www.w3.org/2001/XMLSchema#string

Jonathan M Green

http://www.w3.org/2001/XMLSchema#string

Jonathan S Boomer

http://www.w3.org/2001/XMLSchema#string

Kathleen To

http://www.w3.org/2001/XMLSchema#string

Kathy C Chang

http://www.w3.org/2001/XMLSchema#string

Osamu Takasu

http://www.w3.org/2001/XMLSchema#string

P2860

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

Viral immune evasion due to persistence of activated T cells without effector function

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

Restoring function in exhausted CD8 T cells during chronic viral infection

The pathophysiology and treatment of sepsis

The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis.

IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis.

T-cell exhaustion: characteristics, causes and conversion.

Normal responses to injury prevent systemic inflammation and can be immunosuppressive.

Dysregulation of in vitro cytokine production by monocytes during sepsis

P304

2594-2605

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.2011.1829

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

306

http://www.w3.org/2001/XMLSchema#string

P50

Richard S Hotchkiss

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51904153

http://www.w3.org/2001/XMLSchema#string

P698

22187279

http://www.w3.org/2001/XMLSchema#string

P921

immunosuppression

P932

3361243

http://www.w3.org/2001/XMLSchema#string